Sofinnova Investments’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Sofinnova Investments’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,419,528	Closed	-$150M	–	92
2023 Q4	$150M	Hold	2,419,528	–	–	8.41%	2
2023 Q3	$53.7M	Buy	+2,419,528	New	+$50.8M	3.39%	6

Sofinnova Investments's RYZB Position: Q1 2024 in Review

Sofinnova Investments sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 2,419,528 shares — an estimated $150M sold.

Sofinnova Investments first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $150M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Sofinnova Investments reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Sofinnova Investments sold 2,419,528 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $150M.
Sofinnova Investments first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Sofinnova Investments's RayzeBio, Inc. Common Stock position peaked at $150M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Sofinnova Investments's 13F filing for Q1 2024, filed 15 May 2024.